BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• 

  Genetown

  Boston’s Anti-Aging Startup resTORbio Scores $40M

  This financing brings the total capital raised this year to $65 million, including a $25 million Series A financing that was completed earlier this year.

  November 30, 2017

   · 

  4 min read
• Business

  Golden Meditech Announces FY2017/2018 Interim Results

  Golden Meditech announces today its interim results for the six months ended 30 September 2017.

  November 30, 2017

   · 

  14 min read
• Biotech Beach

  Agena Bioscience’s Liquid Biopsy Technology Awarded Horizon 2020 Grant by European Union

  Agena Biosciences today announced it has been selected to participate as an innovative technology provider in the LIMA project.

  November 30, 2017

   · 

  2 min read
• Business

  Celebrity Trainer and Author Bob Harper Teams up With AstraZeneca to Connect With Fellow Heart Attack Survivors

  Bob Harper and AstraZeneca are asking those who have had a heart attack to visit www.survivorshaveheart.com and submit an essay of 500 words or less about their experience and recovery.

  November 30, 2017

   · 

  7 min read
• 

  Genetown

  Massachusetts’ Fractyl Bags $44M to Advance New Treatment for Type 2 Diabetes

  Proceeds from the financing will be used towards continued development of Fractyl’s Revita DMR technology for patients with type 2 diabetes.

  November 30, 2017

   · 

  3 min read
• Nuvo Pharma Announces Normal Course Issuer Bid

  The normal course issuer bid will be made in accordance with the requirements of the TSX.

  November 30, 2017

   · 

  4 min read
• Deals

  Myomo Announces Pricing of Public Offering

  The warrants have an exercise price of $2.95 per share, are immediately exercisable and will expire on December 4, 2022.

  November 30, 2017

   · 

  3 min read
• Deals

  SQI Diagnostics Completes Sale of Automated Sqidlite Platform to Predictive Cardiac Customer

  SQI Diagnostics today announced it has successfully converted a multi-biomarker cardiac event prediction test from a pioneer in the field of predictive diagnostic medicine, into an SQI-based multiplex test. The test has also been successfully automated on SQI’s “sample-to-answer” sqidlite system.

  November 30, 2017

   · 

  3 min read
• Immune Therapeutics Shareholder Update Letter

  Immune Therapeutics today provided the following letter to shareholders...

  November 30, 2017

   · 

  11 min read
• Business

  Relevium Announces First Quarter Results With Revenues of $1.15M and 13% Adjusted EBITDA Margin

  Relevium is pleased to announce its unaudited financial results for the three-month period ended September 30, 2017.

  November 30, 2017

   · 

  4 min read